Retractable Technologies

Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. It offers injection devices, blood collection devices, and infusion devices. The company was founded by Thomas J. Shaw on May 9, 1994 and is headquartered in Little Elm, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $10.3 million for the third quarter of 2024 and an operating loss of $5.1 million for the period, as compared to total net sales for the same period last year of $10.3 million and an operating loss of $936 thousand. For the first nine months of the year, net sales were $24.0 million and operating losses were $13.9 million as compared to 2023 net revenues of $29.3 million and operat.

Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning July 1, 2024 through September 30, 2024. The dividends will be paid on October 21, 2024.

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announces that on September 26, 2024, it filed a complaint in the United States Court of International Trade against defendants involved in the issuance of a recent decision implementing a 100% tariff on syringes and needles imported from China, effective September 27, 2024. Such defendants include the United States of America, the Office of the United States Trade Representative, Trade Representative Kather.

Retractable Technologies, Inc. Files Complaint in United States Court of International Trade

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announces that on September 13, 2024, the Office of the United States Trade Representative (“USTR”) revealed final adjustments to tariffs placed on Chinese imported syringes and needles. Despite initially proposing a 50% rate, the USTR set the tariff at 100% effective September 27, 2024. Retractable's competitor, Becton, Dickinson and Company (“BD”), requested an increase to “the maximum tariff level availab.

Tariffs Finalized on Chinese Imports

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $6.0 million for the second quarter of 2024 and an operating loss of $5.8 million for the period, as compared to total net sales for the same period last year of $8.0 million and an operating loss of $5.0 million. For the first half of the year, net sales were $13.6 million and operating losses were $8.7 million as compared to 2023 net revenues of $19.0 million and operating losses.

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2024

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.6 million for the first three months of 2024 and an operating loss of nearly $3.0 million for the period, as compared to total net sales for the same period last year of $11.0 million and an operating loss of $2.7 million. The differences in the revenues and operating losses are largely due to the lack of syringe sales to the international market for COVID-19 vaccination efforts.

Retractable Technologies, Inc. Results for the Period Ended March 31, 2024

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2023. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed on March 29, 2024 with the U.S. Securities and Exchange Commission. Our revenues for 2023 decreased 54.0% as domestic and international COVID-19 vaccination sales decreased. We had revenues of approximately.

Retractable Technologies, Inc. Reports Results for 2023

OPKO Health

Texas Pacific Land Trust

Active traders use many fundamental or technical signals to set up their trades. Stocks exhibiting heavy insider buying can be one of these signals.

3 Stocks with Major Insider Buying This Month

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that the FDA Safety Communication “Evaluating Plastic Syringes Made in China for Potential Device Failures” on November 30, 2023 does not refer to syringes from Retractable Technologies Inc. The FDA identified quality issues related to “leaks, breakage, and other problems after manufacturers made changes to the syringe dimensions.” Retractable Technologies has not incorporated any recent changes to t.

Retractable Technologies, Inc. Not Impacted by FDA Safety Communication

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its loss from operations was $8.7 million for the first nine months of 2023 and that it had an operating loss of $936 thousand for the third quarter of 2023, as compared to an operating income for the same periods last year of $7.0 million for the first nine months of 2022 and an operating loss of $691 thousand for the third quarter of 2022. Total net sales were $10.3 million for the three month.

Retractable Technologies, Inc. Results for the Periods Ended September 30, 2023

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $8.0 million for the second quarter of 2023 and an operating loss of $5.0 million for the second quarter, as compared to total net sales for the same quarter last year of $14.3 million and an operating loss of $2.1 million. For the first half of the year, 2023 net revenues were $19.0 million and operating losses were $7.8 million as compared to 2022 net revenues of $59.1 million an.

Retractable Technologies, Inc. Results for the Period Ended June 30, 2023

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $11.0 million for the first three months of 2023 and an operating loss of $2.7 million for the period, as compared to total net sales for the same period last year of $44.7 million and an operating income of $9.7 million. The differences in the revenues and operating income or loss are largely due to the lack of syringe sales to the U.S. government for COVID-19 vaccination efforts.

Retractable Technologies, Inc. Results for the Period Ended March 31, 2023

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2022. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed on March 30, 2023 with the U.S. Securities and Exchange Commission. Our revenues for 2022 decreased 49.7% as sales to the U.S.

Retractable Technologies, Inc. Reports Results For 2022

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that it has reduced its workforce by approximately 22%. The reduction is due to the decreased need for domestic production and production support personnel. The staff reduction primarily affects the Company's production, operations, and logistics departments. The reduction will result in an overall annualized savings of approximately $1.

Retractable Technologies, Inc. Announces Workforce Reduction

Retractable Technologies (NYSE:RVP) is a hidden gem trading below our assessed liquidation value of $2.25 per share. The company is well-positioned to get back into profitable territory soon.

Retractable Technologies Offers At Least 100% Potential Upside

LITTLE ELM, Texas--( BUSINESS WIRE )--Retractable Technologies, Inc. (NYSE American: RVP) announces today that it has agreed to repurchase three million shares of its common stock in a private transaction with BML Investment Partners, L.P. Braden M. Leonard, on behalf of the selling shareholder, approached the Company with an offer to sell a block of shares prior to year-end. The Company accepted, determining it would be advantageous to buy a large block of shares in one transaction, especially given the stock's low price. The parties negotiated a price of $1.60 per share, being an 8% discount from the $1.74 per share closing price as of December 22, 2022.

Retractable Technologies, Inc. Reports Private Stock Repurchase

Alpha Metallurgical Resources

Atkore International Group

Boise Cascade

Kulicke & Soffa Industries

Louisiana-Pacific

Nucor

Sturm, Ruger & Company

Encore Wire

United States Steel

The 10 stocks featured in this article are featured from Fintel's QVM (Quality, Value & Momentum) stock screen this week.

Top 10 Quality, Value & Momentum Quant Stocks for December Revealed Here

LITTLE ELM, Texas--( BUSINESS WIRE )--Retractable Technologies, Inc. (NYSE American: RVP) issues this press release to express the Company's concern regarding stock price anomalies in its Common Stock and disclose actions taken to date. Concerned about possible market manipulation, the Company engaged an independent highly reputable economic consulting firm in 2021 which analyzed millions of trades in the Company's stock in recent years. This in-depth analysis, costing the Company over $600 thousand, confirmed that there were statistically significant anomalies in the market's reaction to the Company's positive disclosures, meaning that the Company's stock price would often react negatively or in a statistically insignificant way following positive earnings reports and press releases. The Company's consultant presented its analysis to the U.S. Securities and Exchange Commission in March 2022. In late November 2022, the Commission informed the Company that it would not pursue the matter further from an enforcement perspective. In summary, the Company's management expresses its disappointment that the Company's stock price does not appear to correlate to the Company's actual value and advises its stockholders that an investment in the Company's stock is not likely to track the Company's operational performance based on historical data.

Retractable Technologies, Inc. Reports Stock Price Anomalies

BrasilAgro Cia Brasileira de Propriedades Agricolas

MIND C.T.I.

Safe Bulkers

Although respected financial analysts consistently steer their clients away from penny stocks, they still attract new recruits. Obviously, the allure of quick riches represents a universal temptation.

7 Penny Stocks Primed for Huge Moves in December

LITTLE ELM, Texas--( BUSINESS WIRE )--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $7.0 million for the first nine months of 2022 and that it had an operating loss of $691 thousand for the third quarter of 2022, as compared to an operating income for the same periods last year of $44.1 million for the first nine months of 2021 and an operating income of $8.0 million for the third quarter of 2021. Total net sales were $23.1 million for the three months ended September 30, 2022 and $82.1 million for the nine months ended September 30, 2022. In comparison, total net sales were $36.4 million for the three months ended September 30, 2021 and $129.0 million for the nine months ended September 30, 2021. The differences in the revenues are largely due to the lack of second and third quarter sales to the U.S. government, offset by much higher international sales. Although total revenues for the three months ended September 30, 2022 were significantly lower than the same periods in the prior year, both domestic and international sales were higher than any quarter ended September 30 in 2018-2019 prior to the COVID-19 pandemic.

Retractable Technologies, Inc. Results for the Periods Ended September 30, 2022

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $7.7 million for the first six months of 2022 and that it had an operating loss of $2.1 million for the second quarter of 2022, as compared to an operating income for the same periods last year of $36.1 million for the first six months of 2021 and an operating income of $12.7 million for the second quarter of 2021. Total net sales were $14.3 million for the three months

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2022

Retractable Technologies has developed a unique product different from its competition. The medical supply industry is a huge growing industry with constant demand to meet healthcare needs.

Retractable Technologies: A Very Promising Small-Cap Healthcare Stock

Retractable Technologies Inc (NYSE: RVP) has reduced its workforce by approximately 16% due to the substantial completion of its facility expansion efforts and the completion of U.S. government orders to provide its products for COVID-19 vaccination efforts.  The staff.

Safety Medical Devices-Focused Retractable Tech Cuts Its Workforce

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that it has reduced its workforce by approximately 16% as a result of the substantial completion of its facility expansion efforts and the completion of U.S. government orders to provide its products for COVID-19 vaccination efforts. The staff reduction primarily affects its production, operations and logistics departments. The reduction will result in an overall annualized savings of approximately $

Retractable Technologies, Inc. Announces Reduction in Workforce

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $9.7 million for the first three months of 2022, compared to an operating income for the same period last year of $23.4 million. Net sales were $44.7 million for the first quarter of 2022 as compared to $50.1 million for the first quarter of 2021, reflecting lower revenues from the U.S. government and higher international revenues related to COVID-19 vaccination efforts.

News for Retractable Technologies Stock (RVP)